Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer: Promising Clinical Target or Only a Marker?

By Monika L. Burness, T. Grushko, O. Olopade. 2010

174 citations recorded by the source corpus.

Subfields: Oncology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yun Bai
2. Tianwei Yu
3. K. J. Chavez
4. Zhaohui S. Qin
5. S. Garimella
6. Rendong Yang
7. S. Lipkowitz
8. Matthew Stephens

Citations in the corpus

• EgoNet: identification of human disease ego-network modules (2014, background): “In the DE group, a notable example of biomarker gene in TNBC, EGFR [56] is present, which suggests the ranking derived by our proposed metric is sensible.”
• Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer (2010, background): “However, the bulk of the data from clinical trials have not demonstrated a great deal of efficacy for EGFR inhibition in TNBC [64].”